Double Medical Technology Inc. (SHE:002901)
China
· Delayed Price · Currency is CNY 44.22
-1.18 (-2.60%)
At close: Mar 9, 2026
Double Medical Technology Revenue
Double Medical Technology had revenue of 665.82M CNY in the quarter ending September 30, 2025, with 17.82% growth. This brings the company's revenue in the last twelve months to 2.48B, up 28.17% year-over-year. In the year 2024, Double Medical Technology had annual revenue of 2.14B with 39.29% growth.
Revenue (ttm)
2.48B
Revenue Growth
+28.17%
P/S Ratio
7.24
Revenue / Employee
551.31K
Employees
4,503
Market Cap
17.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.14B | 602.44M | 39.29% |
| Dec 31, 2023 | 1.53B | 99.02M | 6.90% |
| Dec 31, 2022 | 1.43B | -560.23M | -28.09% |
| Jan 1, 2022 | 1.99B | 407.47M | 25.68% |
| Dec 31, 2020 | 1.59B | 329.54M | 26.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Autobio Diagnostics | 4.22B |
| MeHow Innovative | 1.63B |
| Shandong Weigao Blood Purification Products | 3.70B |
| Jafron Biomedical | 2.04B |
| MGI Tech | 2.78B |
| Beijing Balance Medical Technology | 630.37M |
| Shanghai MicroPort Endovascular MedTech | 1.35B |
| Cofoe Medical Technology | 3.13B |